Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 1, 2009, Pages 124-129

  Wahl, Andreas ^a   Praz, Fabien ^a   Findling, Oliver ^b   Nedeltchev, Krassen ^b   Schwerzmann, Markus ^a   Tai, Tony ^a   Windecker, Stephan ^a   Mattle, Heinrich P ^b   Mejer, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Atrial septal aneurysm; Migraine; Migraine with aura; Patent foramen ovale; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CODEINE; ERGOTAMINE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLIP; CONTRAST ENHANCEMENT; EMBOLISM; EQUIPMENT DESIGN; FEMALE; FLUOROSCOPY; HEART SURGERY; HUMAN; MALE; MIGRAINE; MIGRAINE WITH AURA; MORTALITY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATENT FORAMEN OVALE; PERCUTANEOUS PATENT FORAMEN OVALE CLOSURE; PREVALENCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT RESPONSE; VALSALVA MANEUVER;

ADULT; CEREBROVASCULAR CIRCULATION; DRUG RESISTANCE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EQUIPMENT DESIGN; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68949217225     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21921     Document Type: Article

References (31)

1. Post MC, Luermans JG, Plokker HW, Budts W. Patent foramen ovale and migraine. Catheter Cardiovasc Interv 2007;69:9-14.
2. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, Gandolfo C. Migraine with aura and right-to-left shunt on transcranial Doppler: A case-control study. Cerebrovasc Dis 1998;8:327-330.
3. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999;52:1622-1625.
4. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, Seiler C. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005;65:1415-1418.
5. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: A study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002;13:102-106.
6. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001;100:215-220.
7. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90:1315-1320.
8. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
9. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-1401.
10. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439-1440.
11. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-492.
12. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495.
13. Giardini A, Donti A, Formigari R, Salomone L, Prandstraller D, Bonvicini M, Palareti G, Guidetti D, Gaddi O, Picchio FM. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006;151:922 e1-e5.
14. Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Liebeskind DS. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007;99:1316-1320.
15. Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia. Catheter Cardiovasc Interv 2007;70:429-433.
16. Dubiel M, Bruch L, Schmehl I, Liebner M, Winkelmann A, Stretz A, Grad MO, Kleber FX. Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol 2008;21:32-37.
17. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: A case-control study. Stroke 2006;37:430-434.
18. Post MC, Thijs V, Schonewille WJ, Budts W, Snijder RJ, Plokker HW, Westermann CJ. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006;66:202-205.
19. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404.
20. The international classification of headache disorders: 2nd ed. Cephalalgia 2004;24(Suppl 1):9-160.
21. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurysm and stroke: A transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-1229.
22. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
23. Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 2008;94:336-341.
24. Wahl A, Praz F, Stinimann J, Windecker S, Seiler C, Nedeltchev K, Mattle H, Meier B. Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients. Swiss Med Wkly 2008; 138:567-572.
25. Meier B. Pacman sign during device closure of the patent foramen ovale. Catheter Cardiovasc Interv 2003;60:221-223.
26. Wahl A, Praz F, Seiler C, Windecker S, Meier B. Clinical relevance of coronary angiography at the time of percutaneous closure of a patent foramen ovale. Catheter Cardiovasc Interv 2007;70:641-645.
27. Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988;296:313-316.
28. Diener HC, Hartung E, Chrubasik J, Evers S, Schoenen J, Eikermann A, Latta G, Hauke W. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001;21:120-128.
29. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005;91:1173-1175.
30. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44: 750-758.
31. Wahl A, Krumsdorf U, Meier B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005;45:377-380.